Potential factors affecting adherence with HIV therapy

被引：222
作者：
Mehta, S
Moore, RD
Graham, NMH
机构：
[1] JOHNS HOPKINS SCH MED, DEPT MED, BALTIMORE, MD USA
[2] JOHNS HOPKINS SCH PUBL HLTH & HYG, DEPT EPIDEMIOL, BALTIMORE, MD USA
来源：
AIDS | 1997年 / 11卷 / 14期
关键词：
adherence; antiretrovirals; compliance;
D O I：
10.1097/00002030-199714000-00002
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1665 / 1670
页数：6
相关论文
共 48 条
[1]  
ARNOLD RJG, 1993, SOUTHERN MED J, V86, P208
[2]  
BROERS B, 1994, ARCH INTERN MED, V154, P1121, DOI 10.1001/archinte.154.10.1121
[3]  
CARNEY RM, 1995, HEALTH PSYCHOL, V14, P88, DOI 10.1037/0278-6133.14.1.88
[4]  
*CDCP, 1996, HIV AIDS SURV REP JU
[5]  
*CDCP, 1996, MMWR-MORBID MORTAL W, V45, P733
[6]  
*CDCP, 1996, MMWR-MORBID MORTAL W, V45, P121
[7]   FAILURE OF ANTIRETROVIRAL THERAPY - ROLE OF VIRAL AND CELLULAR FACTORS [J].
CINATL, J ;
CINATL, J ;
RABENAU, H ;
DOERR, HW ;
WEBER, B .
INTERVIROLOGY, 1994, 37 (06) :307-314
[8]  
COONS SJ, 1994, CLIN THER, V16, P110
[9]   PHARMACOKINETIC ADVANTAGES OF ERYTHROMYCIN ESTOLATE OVER ETHYLSUCCINATE AS DETERMINED BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J].
CROTEAU, D ;
BERGERON, MG ;
LEBEL, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (04) :561-565
[10]  
DANIELS DE, 1994, J NATL MED ASSOC, V86, P20
12345